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We  compared  the  behaviour  of  NK1R−/−  mice  and wildtypes  in the  5-Choice  Continuous  Performance  Test.
NK1R−/−  mice  did  not  express  excess  impulsivity  (premature  response  or false  alarms)  in  this  test.
NK1R−/−  mice  expressed  excessive  perseveration,  which  is  common  in ADHD.
The  ﬁndings  point  to a behavioural  phenotype  for  ADHD  patients  with  polymorphism  of  the  TACR1  gene.
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a  b  s  t  r  a  c  t
Mice  lacking  functional  NK1  (substance  P-preferring)  receptors  typically  display  excessive  inattentive-
ness  (omission  errors)  and  impulsivity  (premature  responses)  when  compared  with  wildtypes  in  the
5-Choice  Serial  Reaction-Time  Test  (5-CSRTT).  These  abnormal  behaviours  are  analogous  to  those  seen
in humans  suffering  from  Attention  Deﬁcit  Hyperactivity  Disorder  (ADHD).  Here  we  used the  5-Choice
Continuous-Performance  Test  (5C-CPT)  to  ascertain  whether  NK1R−/−  mice  also  display  excessive  false
alarms  (an  inappropriate  response  to  a  ‘no-go’  signal),  which  is  another  form  of impulsive  behaviour.
NK1R−/−  mice  completed  more  trials  than  wildtypes,  conﬁrming  their  ability  to  learn  and carry  out  the
task. At the start  of Stage  1 of training,  but  not  subsequently,  they  also  scored  more  premature  responses
than  wildtypes.  When  the  mice  were  tested  for  the  ﬁrst time,  neither  false  alarms nor  premature  responses
was  higher  in  NK1R−/−  mice  than  wildtypes  but,  as  in the  5-CSRTT,  the latter  behaviour  was  strongly
dependent  on  time  of  day.  NK1R−/−  mice  expressed  excessive  perseveration  during  all  stages  of  the  5C-
CPT. This  behaviour  is  thought  to reﬂect  compulsive  checking,  which  is common  in ADHD  patients.  Thesempulsivity
otor disinhibition
ﬁndings  point  to differences  in the 5-CSRTT  and  5C-CPT  protocols  that could  be important  for  distinguish-
ing  why  the  cognitive  performance  and  response  control  of  NK1R−/−  mice  differs  from  their  wildtypes.
The  results  further  lead to  the prediction  that  ADHD  patients  with  polymorphism  of  the  TACR1  gene
(the  human  equivalent  of Nk1r)  would  express  more  perseveration, but not  false alarms,  in  Continuous
Performance  Tests  when  compared  with  other  groups  of  subjects.
© 2015  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Attention Deﬁcit Hyperactivity Disorder (ADHD) is a highly
revalent illness, which persists into adulthood in the majority of
ases [1,2]. In childhood, patients suffer from hyperactivity, inat-
ention and impulsivity, which contribute to difﬁculties at school
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and everyday life [3,4]. As adults, ADHD patients commonly expe-
rience co-morbid social, occupational and health problems [3,5].
A limited number of treatments for ADHD are available, but
these were not targeted at the neural mechanisms underlying
the disorder because these mechanisms have yet to be identiﬁed.
Amongst the candidates thought to cause, or increase vulnerabil-
ity to, ADHD is polymorphism(s) of the (human) TACR1 gene [6,7],
which is equivalent to the Nk1 (substance P-preferring) receptor
gene in rodents. Delineating a role for the Nk1r gene in behaviours
relevant to ADHD could enable more targeted development of drug
treatments for this disorder.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Mice with functional ablation of the Nk1r gene have been gen-
rated (‘NK1R−/−’) [8] and we have reported previously that the
ales are hyperactive in a range of environmental contexts: e.g.
n activity meter [9]; a light/dark exploration-box [6,10,11]; and
n their home-cage [12]. Also, when assessed for the ﬁrst time
n a widely-used test of sustained attention, the 5-Choice Serial
eaction-Time task (5-CSRTT) [13,14], NK1R−/− mice typically
espond before stimuli appear (premature response, a form of motor
mpulsivity) and miss responding to stimuli (omission error, a mea-
ure of attention) [11,12,15,16]. These behavioural abnormalities
re arguably analogous to the hyperactivity, impulsivity and inat-
ention seen in ADHD patients.
The inattention and response disinhibition of ADHD patients,
owever, is more commonly quantiﬁed using procedures such as
he Conner’s Continuous Performance Test (CPT) and the Test of
ariables of Attention (TOVA: [17–19]). Both the CPT and TOVA
nclude ‘target’ (’go ’) trials, to which subjects should respond,
nd ‘non-target’ (‘no-go’)  trials, to which they should withhold
ny response (false alarms, in the breach) [19–21]. In the latter
ase, these tests differ from the 5-CSRTT, which incorporates only
‘go’) targets that require responses. For this reason, a 5-Choice
ontinuous-Performance Test (5C-CPT), which includes both tar-
et and non-target trials, was developed to assess vigilance in mice
20–22], rats [23,24] and humans [22,25,26]. A preclinical study
elevant to ADHD has reported that both methylphenidate and ato-
oxetine, which are licensed to treat ADHD, improve attention and
educed response disinhibition in rats that are performing poorly
n the 5C-CPT [27].
Another important feature of the 5C-CPT is that, by including
on-target stimuli, it enables quantiﬁcation of impulsivity in the
orm of both premature responses (as in the 5-CSRTT) and false
larm responses (as in human CPTs). This differentiation is impor-
ant because there is now extensive evidence that there are several
spects of impulsivity [28] and that different types of impulsiv-
ty recruit different neuronal networks [29,30]: i.e. these measures
re neuro-mechanistically dissociable [21]. A further difference
etween the two tests is that a progressive decrement in vigilance
evelops when rodents are tested in the 5C-CPT [20,21,23], which
s rarely seen in the 5-CSRTT.
Here, we further interrogated the putative association between
he NK1 receptor and ADHD by comparing the performance of
K1R−/− mice and their wildtypes during training and testing
n the 5C-CPT. We  hypothesized that Nk1r ‘knockout’ mice would
xhibit increased inattention and impulsivity (premature responses
nd false alarms), which are quantiﬁed in the 5C-CPT as lower vigi-
ance.
. Materials and methods
All procedures complied with the Animals (Scientiﬁc Pro-
edures) Act (UK) [2010/63/EU] and had received local ethical
pproval at University College London.
.1. Apparatus
The apparatus, described in detail elsewhere [15], was  supplied
y Med  Associates (St. Albans, VT, USA) and was  controlled by a
mart Ctrl Package 8IN/16OUT with an additional interface by MED-
C for Windows (Med Associates, St. Albans, VT, USA). The software
as reﬁned to incorporate a no-go signal (see: [20]).
.2. AnimalsAll the mice were bred at University College London and housed
n a facility at 21 ± 2 ◦C, 45 ± 5% humidity, with a 12/12 h light/dark
ycle (lighting increased in steps from 07.00 to 08.00 h). We  usedesearch 298 (2016) 268–277 269
twelve male wildtype mice (aged 6–7 weeks; weight: 30–34 g at
the start of the study) and twelve male NK1R−/− mice of the same
age-range (weight: 29–31 g). Inbred homozygous mice, rather than
the (F2) offspring of heterozygous breeding pairs, were studied.
This is because the incidence of premature responses in the 5-CSRTT
(but not that of omissions or hyperactivity during the dark phase)
depends on an interaction between a lack of Nk1r and breeding
environment and is typically higher than their wildtypes only in
inbred homozygotes [see: [12]]. The two  genotypes shared the
same background strain (129/Sv × C57BL/6J, crossed with outbred
MF1 mice, many (more than 10) generations ago [8]). Wildtype
mice were taken from two breeding pairs and NK1R−/− mice were
taken from three breeding pairs and were group-housed as litter-
mates (2–5 per cage). The home-cages incorporated environmental
enrichment (cardboard tunnels and tissue for nesting material)
and were cleaned twice weekly (bedding: 3Rs Bedding Pty., Ltd.).
They were given free access to water throughout, but were fed a
restricted diet (2018 Global Rodent Diet, Harlan) so as to maintain
their body weight at 90% free-feeding weight. Every weekday, all
the mice were weighed before training/testing in the 5C-CPT and
fed between 16.00 and 17.00 h (after training/testing) with a quota
of food determined by their body weight. At weekends, when there
were no training or testing sessions, the mice were fed with 50%
of their daily quota in the morning (between 09.00 and 11.00 h)
and the remainder was  given in the afternoon (between 16.00 and
18.00 h).
2.3. Training
At the start of the experiment, each mouse was assigned to
one of four test chambers, counterbalancing for genotype, time
of day (for training/testing) and home cage. This conﬁguration
was maintained throughout the experiment. Half the cohort was
trained/tested in one of the morning sessions (three sessions were
run between 10.00 and 12.00 h). The remainder were assigned to
one of the afternoon sessions (three sessions were run between
13.00 and 15.00 h). Individual mice were trained/tested at the same
time each day. All the behavioural data were captured and stored
on-line. Each daily training session lasted for 120 trials or 30 min,
whichever occurred ﬁrst.
The animals carried out the training/test sessions with the
house-light switched off (unlike the 5-CSRTT). After every correct
trial, they were rewarded by delivery of an aliquot of sweetened
milk (10 L), which was available for 4 s. If the mice committed
an omission error, commission error (premature response or false
alarm), or incorrect response, the house-light was turned on for
5 s, as a ‘punishment’, during which time a new trial could not be
initiated (‘time out’).
During Stage 1 of training, the animals experienced only ‘go’
trials, which were delivered at a ﬁxed interval (5 s; ﬁxed ‘ITI’, as in
the 5-CSRTT). In Stage 2, the go signal was  delivered on a variable
intertrial interval schedule (VITI: 3–7 s). Subsequent stages (3 and
4) incorporated no-go, as well as go, signals that were delivered
with a VITI schedule: the ratio of go:no-go signals was 2:1 during
Stage 3 and 5:1 during Stage 4. The mice graduated from one stage
of training to the next when they had satisﬁed the performance
criteria for a minimum of three consecutive days.
After reaching the performance criteria in Stage 4 (‘baseline’:
Table 1), each animal was  tested on the following Friday in an
extended series of trials (‘NI-1’). One difference between NI-1 and
Stage 4 of training was that the number of trials was  increased to
250 trials or 60 min, whichever was  reached ﬁrst. Another was that
the ITIs were increased to 7–11 s. These were delivered in a random
sequence, with the go:no-go signals remaining at a 5:1 ratio. As a
consequence, the signal parameters in NI-1 in this 5C-CPT com-
bined an increase in the latency of the ITIs (reduced event-rate)
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Table 1
Stimulus parameters and progression criteria for training and testing in the 5-CCPT.
Training
Stage Schedule Parameter
Habituation: All holes display a light
signal
Continuous
Progression criteria: >70 reinforcers for 2 consecutive days
Stage 1: Fixed ITI
Go trials, only
ITI: ﬁxed at 5 s
SD ﬁxed: progressively
reduced (s): 20, 10, 8, 4, 2
LH: 2 s longer than SD
(min. 5 s)
Progression criteria (to progress from one SD to the next):
• Mean correct latency (MCL) <0.5 SD for 3 consecutive days
•  At SD of 2 s, animals must achieve at least 10 correct responses for 3 consecutive days
Stage 2: Variable ITI (VITI)
Go trials, only
ITI: 3,4,5,6 or 7 s;
SD: 2 s; LH: 5 s
Progression criteria: Accuracy >80: and %Omissions <40%
Stage 3: Variable ITI (VITI)
2:1 Go/No-go ratio:
(80 Go trials + 40 No-go
trials)
VITI: 3,4,5,6 or 7 s;
SD: 2 s; LH: 5 s
Progression criterion: False Alarms (FA) <0.5
Stage 4: Variable ITI (VITI)
5:1 Go/No-go ratio:
(100 Go trials + 20 No-go
trials)
VITI: 3,4,5,6 or 7 s;
SD: 2 s; LH: 5 s
Progression criterion: Sensitivity Index (SI) >0
Extended test session
Schedule Parameters
250 trials (5:1 Go/No-go
ratio)
VITI: 7,8,9,10,11 s;
SD: 2 s; LH: 5 s
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oD: Stimulus Duration (duration of the light stimulus). LH: Limited Hold (time allow
time  between the start of a trial and the onset of the light stimulus).
ith their delivery in a random sequence (‘VITI’). This approach dif-
ers from the test session (NI-1) of the 5-CSRTT in two  ways. First,
n the 5-CSRTT, NI-1 is the animals’ ﬁrst experience of a VITI and,
econdly, animals’ responses during the VITI and the prolonged ITI
LITI) tests are evaluated separately.
.4. Statistical analysis of the data
The performance variables evaluated in this 5C-CPT include
hose already described for these mice when tested in the 5-CSRTT:
amely, %accuracy,  %omissions,  %premature responses, perseverative
esponses, latency to collect reward and latency to correct response
see: [15]). However, the 5C-CPT provides additional measures
ncluding: the probability of false alarms (pFA: an index of response
isinhibition); hit rate (HR: a measure of an animal’s overall
esponse rate); the latency to false alarms;  the responsivity index (RI:
n index of an animal’s tendency to carry out a motor response trig-
ered by either a go or a no-go light cue); and the sensitivity index
SI: an index of an animal’s sensitivity to go versus no-go stimuli).
he calculation of these behaviours is described fully, elsewhere
20].
InVivoStat (version 2.3.0.0: [31]) was used to analyse the data.
irst, diagnostic plots were constructed to check for normality of
he data-set and equality of the sample variance. When necessary,
he data were transformed (
√
score or Log10(score + 1)) to optimise
he homogeneity of variance across the experimental groups before
roceeding with subsequent analyses. Mead’s resource equation
as used to conﬁrm that sample sizes were adequate to detect
tatistical signiﬁcance.
Data for each of the Stages 1–4 of training were analysedeparately. Those for Stage 1 (ﬁxed ITI phase), were analysed
sing repeated measures ANOVA with ‘Stimulus Duration’ as the
ithin-subjects factor and ‘Genotype’ and ‘Time-of-Day (morning
r afternoon session)’ as between-subjects factors. Subsequently,r a nose-poke response after the onset of the light stimulus). ITI: Intertrial Interval
data for the performance of the mice on their ﬁrst day of training
in Stages 2 (VITI schedule, go signals only) 3 and 4, (VITI, go/no-go
ratio of 2:1 and 5:1, respectively) of training were analysed using
single measure ANOVA with ‘Genotype’ and ‘Time-of-Day’ as the
between subjects factors. The number of daily sessions needed for
the two  genotypes to complete their training (‘total sessions’) was
compared using repeated-measures ANOVA with ‘Genotype’ and
‘Time of Day’ as between-subjects factors.
Data from NI-1 were analysed using single measure ANOVA
with ‘Genotype’ and ‘Time of Day’ as the between subjects factors.
Where there was no main effect of Time of Day, this factor was col-
lapsed on all other factors. Further analyses were conducted within
the session whereby performance was  divided into bins of trials
(50 trials/bin). These bins were analysed using repeated-measures
ANOVA with ‘Trial-Bin’ as the within-subjects factor and ‘Genotype’
and ‘Time-of-Day’ as the between-subjects factors.
ANCOVA was also carried out to ascertain whether any
genotype difference in perseveration could account for a (genotype-
dependent) prolongation of the latency to collect the reward:  i.e. the
number of perseverative responses by individual mice was used as a
covariate in the statistical analysis of its latency to collect the reward.
The post-hoc LSD test was used for pair-wise comparisons of the
experimental groups. In all cases, statistical signiﬁcance was  set at
P < 0.05.
3. Results
For most of the training procedure, there was  no overall dif-
ference in the total number of daily sessions required by wildtype
and NK1R−/− mice to complete each stage of training. However,
NK1R−/− mice required slightly fewer sessions than wildtypes dur-
ing Stage 1, especially during the ﬁnal, most difﬁcult, phase with the
shortest SD [F(1,22) = 4.99; P = 0.036] (Fig. 1A). Consistent with this
slightly and transiently better competence in learning the task, the
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Fig. 1. During training in the 5C-CPT, NK1R−/− mice needed fewer daily sessions to reach performance criteria and they completed more trials than their wildtypes.
Circles/bars show mean ± s.e.m. For Stages 2–4, the bars show data for the ﬁrst day of training, only. A: total sessions required to attain performance criterion at each stage of
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umber of total trials completed by NK1R−/− mice during individ-
al training sessions was higher than that by wildtypes for most
f Stage 1 [F(1,4) = 13.14; P = 0.001] and also Stage 4 [F(1,22) = 5.43;
 = 0.029] (Fig. 1B).
.1. During training, NK1R−/−mice express more premature
esponses, but not false alarms, than wildtypes
During Stage 1 of training, NK1R−/− mice made more premature
esponses (an index of motor impulsivity), overall, than wildtype
ice [F(1,22) = 7.32; P = 0.013], especially during early exposure to
he task (LSD: P < 0.001; Fig. 2A). On the ﬁrst day of training in Stages
 and 4, when the no-go signal was incorporated into the procedure,
oth genotypes carried out some false alarms, but there was  no
enotype difference for this measure of behavioural disinhibition
Fig. 2B). When ﬁrst introduced to the training procedure [Stage
], NK1R−/− mice carried out fewer cued plus uncued responses
‘hit rate’) than wildtype mice (genotype × stimulus duration):
(4,80) = 3.09; P = 0.02; LSD P < 0.01) but there was no genotype dif-
erence in this measure at any subsequent stage of the task (Fig. 2C).
Neither %omissions (an index of inattentiveness) (Fig. 3A) nor
he sensitivity index (an index of ‘vigilance’) (Fig. 3B) differed in the
wo genotypes on the ﬁrst day of any stage of the training process.
owever, %accuracy (an index of selective attention) of NK1R−/−
ice was slightly lower than that of the wildtypes during Stage 1,
specially at the onset of training [F(1,22) = 6.09; P = 0.022] (Fig. 3C).
Perseveration was higher in NK1R−/− mice throughout training
Stage 1: F(1,22) = 8.25; P = 0.009; Stage 2: F(1,22) = 40.34; P < 0.001;
tage 3: F(1,22) = 5.78; P = 0.025; Stage 4: F(1,22) = 11.5; P = 0.003]
Fig. 4A). The responsivity index (an index of animals’ tendency to
espond to any light cue, which is a function of their motivation
nd innate response strategy) did not differ in the two  genotypes
Fig. 4B). Consistent with this, there was no difference in latency
o correct response at any stage of training (Fig. 4C). The latency to
ollect the reward was higher in NK1R−/− mice on the ﬁrst day
f Stages 2–4 (Fig. 4D) [Stage 2: F(1,22) = 16.1; P < 0.001; Stage 3:
(1,22) = 6.04; P = 0.022; Stage 4: F(1,22) = 5.08; P = 0.034]. However,
NCOVA conﬁrmed that this increase could be attributed to the
igher perseveration score for NK1R−/− mice, which delayed theirus durations (SD: gradually reduced from 20 to 2 s as animals achieved progression
/− and wildtype mice. Statistical signiﬁcance of differences between pairs of data
excursion to the magazine to collect their reward [F(1,19) = 0.25;
P = 0.63].
3.2. NK1R−/− mice do not carry out more false alarms,
premature responses, or omissions during the extended test phase
(NI-1) of the 5C-CPT
Total trials completed during the test session (NI-1) was
again higher for NK1R−/− mice (213.4 ± 7.7) than wildtypes
(178.6 ± 11.0).
An apparently higher hit rate (i.e. total motor responses,
whether or not promoted by a light cue) of NK1R−/− mice
during NI-1 just missed the criterion for statistical signiﬁcance
(WT: 126 ± 10.8; NK1R−/−: 155 ± 9.4; t(22) = 2.05; P = 0.052). There
was a high incidence of false alarms for both genotypes but,
contrary to our predictions, the probability of a false alarm dur-
ing NI-1 was  slightly lower in NK1R−/− mice than wildtypes
[F(1,22) = 5.31; P = 0.031] (Fig. 5A). There was  also no overall geno-
type difference in the incidence of premature responses. However,
as in our previous studies using the 5-CSRTT, the incidence of
this behaviour depended on time of day [Geno × Time-of-Day:
F(1,20) = 5.47; P = 0.03] (Fig. 5B): wildtypes produced fewer prema-
ture responses in the afternoon compared with the morning (LSD:
P = 0.042) whereas there tended to be an increase in this behaviour
by NK1R−/− mice. A genotype difference in premature responses
in the morning just missed the criterion for signiﬁcance (LSD:
P = 0.072).
The sensitivity index was higher for NK1R−/− mice than wild-
types [F(1,22) = 4.46; P = 0.046), suggesting that the former genotype
was more vigilant, possibly even hypervigilant (Fig. 5C). Never-
theless, there was no genotype difference in either %omissions
(F(1,22) = 0.18; P = 0.679; Fig. 5D) or %accuracy [F(1,22) = 0.33; P =0 .57]
(Fig. 5E).
Once again, perseveration was higher in NK1R−/− mice than
wildtypes (F(1,22) = 27.65; P < 0.001) (Fig. 6A). An apparent differ-
ence in the responsivity index, suggesting that NK1R−/− mice are
more conservative about responding to the light signal, was not
statistically signiﬁcant [F(1,22) = 3.72; P = 0.067] (Fig. 6B). Both the
latency to correct response (F(1,22) = 8.38; P = 0.008) (Fig. 6C) and
latency to reward (F(1,22) = 5.95; P = 0.023) (Fig. 6D) were increased
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Fig. 2. NK1R−/− mice carried out more premature responses and had a lower hit rate than wildtypes at the onset of training in Stage 1 of the 5C-CPT. Circles/bars show
mean  ± s.e.m. For Stages 2–4, the bars show data for the ﬁrst day of training, only. A: % premature responses; B: probability of false alarms; and C: hit rate. Numbers on abscissae
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mor  Stage 1 specify the stimulus durations (gradually reduced from 20 to 2 s as an
ifference between NK1R−/− and wildtype mice. Statistical signiﬁcance of differe
**P < 0.001. N = 12 per group.
n NK1R−/− compared to wildtype mice, albeit by only 0.1 s,
pproximately. However, as during training, there was  no geno-
ype difference in latency to reward when perseveration was treated
s a covariate in the analysis (F(1,19) = 0.25; P = 0.63).
ig. 3. Attention in the 5C-CPT: NK1R−/− mice were less accurate than wildtypes at th
he  bars show data for the ﬁrst day of training, only. A: %omissions; B: sensitivity index; a
gradually reduced from 20 to 2 s as animals achieved progression criteria). A line above
ice.  Statistical signiﬁcance of differences between pairs of data (compared by genotypeachieved progression criteria). A line above graphs/bar charts indicates an overall
between pairs of data (compared by genotype) indicated by: *P < 0.05; **P < 0.01;During the test challenge, in which the ITIs were increased,
both the probability of false alarms [F(4,71) = 4.26; P = 0.004] (Fig. 7A)
e onset of training in the 5C-CPT. Circles/bars show mean ± s.e.m. For Stages 2–4,
nd C: %accuracy.  Numbers on abscissae for Stage 1 specify the stimulus durations
 graphs/bar charts indicates an overall difference between NK1R−/− and wildtype
) indicated by: *P < 0.05; **P < 0.01; ***P < 0.001. N = 12 per group.
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Fig. 4. By comparison with wildtypes, NK1R−/− mice carried out more perseverative responses and had a longer latency to collect their reward during training and testing
in  the 5C-CPT. Circles/bars show mean ± s.e.m. A: perseveration score; B: responsivity index; C: latency to correct response; D: latency to collect reward. Numbers on abscissae
for  Stage 1 specify the stimulus durations (gradually reduced from 20 to 2 s as animals achieved progression criteria). A line above graphs/bar charts indicates an overall
difference between NK1R−/− and wildtype mice. Statistical signiﬁcance of differences between pairs of data (compared by genotype) indicated by: *P < 0.05; **P < 0.01; ***
P < 0.001. N = 12 per group.
Fig. 5. During the extended test session of the 5C-CPT (‘NI-1’), NK1R−/− mice expressed fewer false alarms and had a higher sensitivity index than wildtypes, but genotype
differences in premature responses depended on time of day. Bars show mean ± s.e.m. Lines linking bars indicate statistically signiﬁcant differences between groups. * P < 0.05,
**P < 0.01, ***P < 0.001. N = 12 per group.
274 A.J. Porter et al. / Behavioural Brain R
Fig. 6. During the extended test session of the 5C-CPT (‘NI-1’), NK1R−/− mice had
a  higher perseveration score than wildtypes and a longer latency to correct response
and  latency to collect their reward. Bars show mean ± s.e.m. Lines linking bars indicate
statistically signiﬁcant differences between groups. *P < 0.05, **P < 0.01, *** P < 0.001.
N  = 12 per group.
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during the test phase of the 5C-CPT
NK1R−/− mice carried out more premature responses than wild-
F
a
m
ond %premature responses [F(4,64) = 30.72; P < 0.001] (Fig. 7B and C)
ecreased progressively through the NI-1 testing period. In the
orning session, wildtypes expressed more premature responses
uring the ﬁrst 50 trials of the test (P = 0.015) but this genotype
ifference was not seen in the afternoon because wildtype mice car-
ied out fewer premature responses in these sessions (P = 0.006). As a
onsequence, NK1R−/− mice expressed more premature responses
han wildtypes during trials 51–100 of the afternoon session
P = 0.023). Overall hit rate did not differ in the two  genotypes, apart
rom during the last bin of trials when this measure was  slightly
igher in NK1R−/− mice (Fig. 7D).
The sensitivity index was higher in NK1R−/− mice than wild-
ypes during the ﬁrst trial bin (1–50) but this difference dissipated
ubsequently (Fig. 7E). There was no difference in %omissions, over-
ll, despite an apparent increase in wildtypes in the last time-bin
Fig. 7F). Finally, %accuracy was stable during the test and did not
iffer in the two genotypes (Fig. 7G).
ig. 7. Changes in the performance of NK1R−/− mice and their wildtypes during the exte
bscissae indicate bins of trials within NI-1. Although the performance of the two  genotype
easure. With the exception of the Probability of False Alarms and %Accuracy,  post hoc co
ne  trial-bin, only. *P < 0.05; ***P < 0.001; (Genotype comparison) $P < 0.05 (Time-of-Day cesearch 298 (2016) 268–277
4. Discussion
4.1. The ability to learn the 5C-CPT is not impaired in NK1R−/−
mice
Mice lacking functional NK1R express behavioural abnormali-
ties that are arguably analogous to those seen in ADHD. Here, we
have compared the behaviour of NK1R−/− mice and their wildtypes
in the 5C-CPT. This task presents both target and non-target stim-
uli, as do Continuous Performance Tests that are used to evaluate
attention and impulsivity of ADHD patients.
The 5C-CPT has been used successfully in the past to study
mice, including C57BL6 and DBA/2 strains [20]. Nevertheless, our
ﬁrst step was to ensure that NK1R−/− mice and their wildtypes
could perform the test, which our ﬁndings conﬁrmed. In fact, com-
pared with wildtypes, NK1R−/− mice needed fewer sessions and
completed more trials when training in Stages 1 and 4. This ﬁnd-
ing echoes evidence that the selective NK1R antagonist, SR140333,
reverses stress-induced impairment of novel object/location recog-
nition tests of rodents [32] and promoted inhibitory (step-through)
avoidance of a footshock [33]. Furthermore, ADHD children show
no evidence of learning deﬁcits in a cued, instrumental-learning
task [32–34] provided that attentional demands are low [34,35,see
also: 36,37].
It is unlikely that a higher appetitive motivation explains why
NK1R−/− mice completed more trials in this 5C-CPT. This is because
there was  no genotype difference in their latency to respond. More-
over, latency to collect the reward was  longer in NK1R−/− mice than
wildtypes, although this latter measure is confounded by a higher
incidence of perseveration in NK1R−/− mice (see below), which
delays their excursion to the reward magazine. Although NK1R−/−
mice are smaller than wildtypes (see Section 2), there was no geno-
type difference in food consumption after correcting for differences
in body size (unpublished results). Nevertheless, we acknowledge
that other factors, not accessible to measurement in this 5C-CPT,
could increase the motivation of NK1R−/− mice to perform the task.
4.2. NK1R−/− mice are not more impulsive than wildtypestypes only at the onset of Stage 1 of training in this 5C-CPT. It is
nded test session (NI-1) of the 5C-CPT. Circles show mean ± s.e.m. Numbers on the
s changed during NI-1, there was  no overall genotype difference for any behavioural
mparisons of pairs of data revealed differences between the two genotypes but in
omparison (AM versus PM)).
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nteresting that this Stage resembles the 5-CSRTT in that it incor-
orates go but not no-go,  signals. It is also notable that these inbred
K1R−/−mice typically carried out more premature responses in
he 5-CSRTT when tested with a VITI, but not the LITI (see below)
11,12,15,16]. One explanation for this disparity is that, in the 5-
SRTT, the signal latency (ITI) is constant during each stage of
raining and so the NI-1 test was the animals’ ﬁrst experience of an
npredictable ITI (VITI). By contrast, in this 5C-CPT, a VITI was  used
uring both Stages 2–4 of training and the extended test session
NI-1). We  have reported that a genotype difference in premature
esponses in the 5-CSRTT dissipates on repeated exposure to a VITI
40] and, in this study, the incidence of this behaviour declined
ven within the test session. Evidently, on repeated experience of
he VITI, animals become more proﬁcient at suppressing prema-
ure responses, as do ADHD patients [39], and this could abolish any
enotype-dependent difference in this behaviour.
This evidence leads to the interesting possibility that a differ-
nce in premature responses by NK1R−/− mice and wildtypes in
hese tests depends on whether or not subjects expect the ITI to
e unpredictable. Such a response contingency echoes a compu-
ational analysis [40], which inferred that a phasic response by
oradrenergic neurones within the nucleus locus coeruleus sig-
als a change in the predictability of a target, go/no-go stimulus
‘unexpected uncertainty’). Hence, it is also possible that the intro-
uction of the non-target stimuli in Stage 3 of the 5C-CPT could
ave advanced this elevated noradrenergic response and changed
he subsequent behaviour of the mice. There is also evidence that
 deﬁcit in functional NK1R impairs noradrenergic transmission in
he mouse prefrontal cortex [6,41,42]. To the best of our knowledge,
linical studies have not compared the effects of such a change
n signal predictability in CPTs on premature responses of ADHD
atients and other subjects.
Two more potentially important differences in the protocols for
his 5C-CPT and the 5-CSRTT could inﬂuence our ﬁndings. First,
he NI-1 for the former test incorporated both an LITI and a VITI,
hereas these were tested separately in the 5-CSRTT. Secondly, the
uration of the VITIs used in the 5C-CPT (7–11 s) spanned a nar-
ower time-frame than those used in the 5-CSRTT (2–15 s). Given
hat the likelihood of a premature response increases with longer
TIs, it is possible that only ITIs of duration ≥10–11 s distinguish a
enotype difference in the number of premature responses.
Another ﬁnding was that premature responses in this 5C-CPT
epended on whether the mice were tested in the morning or after-
oon, as in the 5-CSRTT when using the LITI [11,15,38]. Only when
 VITI was used in the 5-CSRTT was there a higher incidence of pre-
ature responses by NK1R−/− mice, regardless of time of day [see
bove; [15,16]]. Obviously, we cannot compare directly the ﬁndings
rom this study with those from the 5-CSRTT. However, collectively,
hey suggest that an inﬂuence of NK1R on premature responses,
hich depends on time of day, is evident only when the latency
LITI) of the target stimulus is consistently longer than anticipated
n the basis of the training schedule.
It is well-known that, when conditioned stimuli are delivered
ith a ﬁxed ITI, subjects use the time-elapsed since the last stimulus
o cue their response (‘interval-timing’). It follows that an error in
nterval-timing could contribute to an apparent increase in prema-
ure responses when testing with an LITI. Indeed, there are reports
f errors in interval-timing by ADHD patients [43–48] and that
recision of interval-timing by humans follows a diurnal rhythm
49,50]. This is interesting because this diurnal rhythm is disrupted
n ADHD patients (e.g. [51]) as is the 24 h rhythm for the locomo-
or activity of NK1R−/− mice [12]. To the best of our knowledge,
here are no reports that the frequency of premature responses in
umans has a diurnal rhythm but this possibility should be taken
nto account when using a ﬁxed ITI to compare ADHD patients with
ther groups of subjects.esearch 298 (2016) 268–277 275
By contrast, false alarms comprise an inappropriate response
to a no-go signal, after it has been delivered and so will not be
confounded by either errors in interval-timing or the schedule for
delivery of the light cue (i.e. LITI versus VITI). However, NK1R−/−
mice carried out fewer false alarms than wildtypes, during the
extended test session. This ﬁnding does not necessarily undermine
the validity of the NK1R−/− mouse in preclinical studies of ADHD.
Despite reports that ADHD patients carry out more false alarms than
controls (e.g. [52–54]), this is not a consistent ﬁnding (e.g. [55–59])
and the use of this behaviour to distinguish ADHD patients from
other groups of subjects is controversial (see: [60]).
4.3. Inattentiveness (accuracy, omissions and sensitivity index)
In the 5-CSRTT, accuracy is used as one index of attention [14,61]
and can be slightly impaired in NK1R−/− mice [[12,15], but see:
[16]]. Here, NK1R−/− mice were less accurate than wildtypes, but
only at the start of training in Stage 1, suggesting that rehearsal of
the task improves this aspect of attention. Whether or not accuracy
is impaired in ADHD is unclear. One report suggests that ADHD
patients do not exhibit lower accuracy in the human 5-CSRTT [62]
but recent evidence suggests that lower accuracy in ADHD could
reﬂect an endophenotype [63].
Another index of attention, %omissions, which is typically higher
in NK1R−/− mice when tested in the 5-CSRTT, did not differ in
the test session (NI-1) of this 5C-CPT (c.f., [12,15]). This is possi-
bly because of the animals’ previous experience of the VITI, during
training, ([see: [38]]) and/or the shorter stimulus latencies in this
5C-CPT, which will diminish the likelihood of an omission error.
A third aspect of attention, the sensitivity index (an index of ‘vigi-
lance’), was  higher in NK1R−/− mice but this can be attributed to
the lower incidence of false alarms.
Evidently, different measures of ‘attention’ are affected by a lack
of functional NK1R in different ways in both the 5-CSRTT and the
5C-CPT. These disparities could give important clues to the role of
NK1R on each of these aspects of attention.
4.4. Perseveration
Perseveration by NK1R−/− mice was  higher than wildtypes
throughout the procedure, as in most of our 5-CSRTT studies
[15,38,64,65]; but see [11,12]. It is unlikely that the increased
perseveration of NK1R−/− mice is explained by a higher rate of non-
speciﬁc motor responses because their hit rate did not differ from
wildtypes. Also, there was  no genotype difference in the respon-
sivity index, during either training or the test session, as has been
reported for ADHD patients [66], also, albeit not consistently (e.g.
[47]).
Isolation-reared rats similarly express increased perseveration in
the 5-CSRTT and this was interpreted as reﬂecting cognitive inﬂex-
ibility [67]. Some ADHD patients also express this behaviour in
the Wisconsin Card Sorting Test [68] and Continuous Performance
Tests [66] (e.g. [66]). In ADHD, perseveration is thought to reﬂect
repetitive (compulsive) ‘checking’ to compensate for their attention
deﬁcit [69,70]. Testing NK1R−/− mice in cross-species cognitive
ﬂexibility-speciﬁc tasks (e.g. [71,72]) would help to interpret this
element of the NK1R−/− mouse behavioural phenotype.
Summary
NK1R−/− mice did not exhibit excessive false alarms,  compared
with wildtypes (response disinhibition) but, as in the 5-CSRTT,
they exhibited more perseverative responses throughout the 5C-
CPT. These results suggest that a subgroup of ADHD patients with
polymorphism of the TACR1 gene (the human equivalent of Nk1r)
might similarly express more perseveration,  but not false alarms,
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n Continuous Performance Tests. Furthermore, our ﬁndings point
o certain procedural parameters, especially the latency and pre-
ictability of the light cue, that could be crucial for distinguishing
he behavioural phenotypes of NK1R−/− mice and their wildtypes
nd, possibly, the characterisation of ADHD patients with polymor-
hism of the TACR1 gene.
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